We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Press releases

Press releases

Novasep’s EUR 4 million plant extension for commercial ADC payload manufacturing now commissioned

15 May 2014

The new Highly Potent API (HPAPI) manufacturing capacity at the Le Mans facility will boost Novasep’s ability to meet customer demand for producing anti-cancer therapies.


Novasep reports full year 2013 results showing strong growth and beating guidance

27 Mar 2014

France, March 27th, 2014 - Novasep, a leading supplier of manufacturing solutions to Life Science industries, today announces its unaudited consolidated results1 for the period ended December 31st, 2013.


Novasep appoints CEO Michel Spagnol as Chairman of the Supervisory Board, Novasep presents strategic developments

04 Mar 2014

Pompey, France, March 4, 2014 - Novasep, a leading provider of global manufacturing solutions for life science molecules and fine chemicals, today announces the appointment of Michel Spagnol as chairman of the Supervisory Board, following the departure of Roger-Marc Nicoud, the founder of the group. Novasep provides an update of its strategic projects.


Novasep attracts top talent to complete its executive team

16 Jan 2014

Thierry Van Nieuwenhove, a seasoned CMO top executive, joins Novasep as president of the Synthesis Business Unit.


Novasep expands and opens subsidiary in India

10 Dec 2013

Novasep Process Engineering Services PVT LTD will meet India’s increasing need for high efficacy processes for its fast growing food and feed industries.


Novasep Launches Chinese Website

03 Dec 2013

Pompey, France, 03 December 2013 - Novasep is proud to announce the launch of their new website in Chinese to better serve clients and partners in China. Novasep’s offering is particularly adapted to the specific market needs of this region, and this new website makes information more readily available to Chinese speakers.


Novasep appoints Nadege Laborde as president of its Industrial Biotech Business Unit

19 Nov 2013

This internal promotion strengthens the business unit and enhances the Executive Committee (COMEX).


Novasep’s European custom manufacturing passes FDA inspection

22 Oct 2013

Two successful FDA inspections assure customers of Novasep’s strict compliance with US pharmaceutical processing standards.


Novasep appoints Christian Thiry as Chief Financial Officer

28 Aug 2013

CFO appointment is a key milestone in Novasep’s senior management recruitment program.


Michel Spagnol appointed President and CEO of Novasep

26 Jun 2013

Pompey, France, 26 June 2013 - Novasep, a leading provider of purificationbased manufacturing solutions for life sciences molecules, today announces the appointment of Michel Spagnol as President and CEO of the company, effective from 25 June 2013. He will succeed Patrick Glaser, who after three years at Novasep in France, has decided to return to the USA. Michel Spagnol joins Novasep from Shasun, where he was President and Chief Technology Officer. He is a proven business leader with core expertise in leading contract manufacturing of active pharmaceutical ingredients and, more broadly, strong experience in using and developing innovative technologies to address needs of customers in fine chemicals and life sciences fields. Prior to Shasun Michel Spagnol spent his career at Rhodia in Lyon and Cranbury (NJ, USA) where he progressed first in technical R&D leadership roles and subsequently transitioned to business development as a Sales and Marketing Vice President of Rhodia Pharma Solutions.



You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!